Efficacy of BIBF 1120 or BIBF 1120 plus chemotherapy on nasopharyngeal carcinoma in vitro and in vivo

PURPOSE: BIBF 1120 is a potent triple angiokinase inhibitor now being evaluated in many types of tumors. We examine the antitumor effects of BIBF 1120 on nasopharyngeal carcinoma (NPC) in vitro and in vivo. MATERIALS AND METHODS: The effect of BIBF 1120 on NPC cell proliferation was evaluated using...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Cong, Tian, Ying, Zhang, Jing, Zhao, Yuanyuan, Zhan, Jianhua, Fang, Wenfeng, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801128/
https://www.ncbi.nlm.nih.gov/pubmed/27042009
http://dx.doi.org/10.2147/DDDT.S96634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801128/
https://www.ncbi.nlm.nih.gov/pubmed/27042009
http://dx.doi.org/10.2147/DDDT.S96634

Ejemplares similares